Waters Corporation (WAT) stock gains as the FDA clears the company's Onclarity HPV self-collection kit for use with BD’s (BDX ...

The life sciences and diagnostics company said Wednesday the regulator cleared its Onclarity HPV Self-Collection Kit and approved the BD Onclarity HPV Assay with extended genotyping for at-home use.

For the first time, women in the United States have the ability to self-collect a sample to screen for human papillomavirus (HPV). This week, the U.S. Food and Drug Administration approved two ...

HPV-positive circulating tumor (ct)DNA after chemoradiation (CRT) for cervical cancer had an independent association with worse outcomes, suggesting potential as a biomarker to guide decision-making, ...